Click on the subcategory below to find drug monographs for that particular area.
Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer.
Newly approved anticancer drugs that do not have a specific molecular target on cancer cells are associated with increased toxicity and the accompanying costs of management.
A study hints that exposure to dim light at night may make human breast cancer tumors resistant to doxorubicin.
The risk of medical professional liability claims alleging failure to screen for esophageal cancer is not a reason to screen for esophageal cancer, according to a newly published research letter.
Trastuzumab (Herceptin) is the best drug treatment for human epidermal growth factor receptor 2-positive breast cancer and should remain the standard of care for that type of tumor, according to new research.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...
Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...
This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...